USANA Health Sciences (NYSE:USNA) and Tilray (NASDAQ:TLRY) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability and dividends.
Earnings and Valuation
This table compares USANA Health Sciences and Tilray’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|USANA Health Sciences||$1.05 billion||2.77||$62.53 million||$4.06||29.45|
|Tilray||$20.53 million||494.46||-$7.80 million||N/A||N/A|
USANA Health Sciences has higher revenue and earnings than Tilray.
This is a breakdown of recent ratings and target prices for USANA Health Sciences and Tilray, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|USANA Health Sciences||0||0||2||0||3.00|
USANA Health Sciences currently has a consensus target price of $135.00, suggesting a potential upside of 12.91%. Tilray has a consensus target price of $135.67, suggesting a potential upside of 24.48%. Given Tilray’s higher probable upside, analysts clearly believe Tilray is more favorable than USANA Health Sciences.
This table compares USANA Health Sciences and Tilray’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|USANA Health Sciences||7.57%||30.37%||22.10%|
Insider and Institutional Ownership
52.2% of USANA Health Sciences shares are held by institutional investors. Comparatively, 0.0% of Tilray shares are held by institutional investors. 53.2% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
USANA Health Sciences beats Tilray on 8 of the 10 factors compared between the two stocks.
About USANA Health Sciences
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Sensébeautiful science products, such as personal care products that support healthy skin and hair through topical nourishment, moisturization, and protection; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.